The AI Inflection Point: How Foundation Models Are Rewriting the Rules of Drug Discovery
Broadcast Date: November 4, 2025 The pharmaceutical landscape is undergoing a transformation that many industry observers describe as the most...
drug
The Era of Modality Convergence: Why Drug Development Is Being Rewritten
The life sciences industry stands at a pivotal juncture. For the better part of the 20th and early 21st centuries,...
Revolutionizing Biopharma: The Antibody Developability Consortium Launches to Decode Drug Success with AI
In a landmark move for the biotechnology and pharmaceutical sectors, Ginkgo Bioworks—through its data-focused arm, Ginkgo Datapoints—and the federated learning...
Transcripta Bio Secures $24M to Pioneer Transcriptome-Based Drug Discovery
In the high-stakes arena of modern pharmaceutical research, where the attrition rate for new drug candidates often exceeds 90%, a...
Lonza and Engitix Forge Strategic Alliance to Pioneer ECM-Targeted Antibody-Drug Conjugates
In a significant move that bridges the gap between extracellular matrix (ECM) biology and advanced bioconjugation chemistry, Lonza and Engitix...
Precision Oncology’s New Frontier: The “Click-to-Assemble” Strategy Overcoming Drug Resistance
The landscape of cancer therapy has been fundamentally transformed by the advent of antibody-drug conjugates (ADCs)—potent, "guided-missile" pharmaceuticals designed to...
The Precision Frontier: Navigating the Complex Analytical Landscape of Antibody-Drug Conjugate Development
In the rapidly evolving theatre of oncology, few modalities have garnered as much clinical excitement as antibody-drug conjugates (ADCs). Often...
AI-Driven Drug Discovery and Corporate Governance: A Mid-Year Pulse Check on Insilico Medicine and Vaxart
The landscape of modern biotechnology is currently defined by two diverging paths to value creation: the high-velocity, algorithmic precision of...
The Digital Frontier: How Virtual Cell Models Are Rewriting the Rules of Drug Discovery
The landscape of modern medicine is currently undergoing a paradigm shift, one that is moving away from the slow, iterative...
Bioinspired Nanotherapy: A New Frontier in the Battle Against Drug-Resistant Candida
In a breakthrough that could fundamentally alter the landscape of infectious disease treatment, researchers from the University of California, San...
Accelerating Drug Development: IDBS and Alchemi Forge Strategic Alliance to Revolutionize Regulatory Compliance with Agentic AI
In a move set to redefine the speed of pharmaceutical innovation, IDBS—a premier provider of cloud-based software solutions for the...
Merck and Protillion Biosciences Forge $510M AI-Driven Drug Discovery Partnership
In a significant move to reshape the future of biologics, pharmaceutical giant Merck & Co. has entered into a multi-target...
